Bard's projected earnings for 2004 are $4.20 a share so the forward PE is only about 22 and a fraction.
Still the stock does seem fully priced at current levels and several price swings are probable over the course of the year.
For a long-term holder the question is to just sit tight or to try to play the swings for a few bucks?
-- Mark --
In life as in mathematics, things go up, peak, and then come down. It is usually referred to as a parabola. IMHO that is Bard at this time, especially if you have been on that great ride UP for as long as I have. 30 X present earnings is a very, very, rosy projection for Bard. I believe that a price at that level won't be supported until 2007 or so. I've put my profits to work elsewhere.
Yep, take out the one time charge and the performance was substantially over last period. Also with $400 million cash $58 million is not a problem. Would not want to do it every quarter but not a problem now. Bard doing a great job with the analysts--keeping them informed and hitting the number they say they will. $93 is high and I think a split will be announced soon.
As in the past - Bard stock rises significantly 3 ways.
1. Always before internal stock option distribution - usually betwen April - July.
2. Buyout speculation - Bard is always in talk in the device arena to be mergered into another lean and mean company.
3. Significant Mgt decisions realted to changes or new actions.
My guess this time is buyout rumours. Their product lines are mature and invaluable in the hospital arena. This is great to a Salesman offering other products that can't get into the mainstream - what better way than to have the Bard lines. One concern at $90 plus I don't think many companys would be interested at that level. But who knows? Anyway this board is always so flat for conversation from the investors and internal people. So does anyone have other input.